TY - JOUR
T1 - Common Susceptibility Loci for Male Breast Cancer
AU - Maguire, Sarah
AU - Perraki, Eleni
AU - Tomczyk, Katarzyna
AU - Jones, Michael E.
AU - Fletcher, Olivia
AU - Pugh, Matthew
AU - Winter, Timothy
AU - Thompson, Kyle
AU - Cooke, Rosie
AU - Trainer, Alison
AU - James, Paul
AU - Bojesen, Stig
AU - Flyger, Henrik
AU - Nevanlinna, Heli
AU - Mattson, Johanna
AU - Friedman, Eitan
AU - Laitman, Yael
AU - Palli, Domenico
AU - Masala, Giovanna
AU - Zanna, Ines
AU - Ottini, Laura
AU - Silvestri, Valentina
AU - Hollestelle, Antoinette
AU - Hooning, Maartje J.
AU - Novaković, Srdjan
AU - Krajc, Mateja
AU - Gago-Dominguez, Manuela
AU - Castelao, Jose Esteban
AU - Olsson, Hakan
AU - Hedenfalk, Ingrid
AU - Saloustros, Emmanouil
AU - Georgoulias, Vasilios
AU - Easton, Douglas F.
AU - Pharoah, Paul
AU - Dunning, Alison M.
AU - Bishop, D. Timothy
AU - Neuhausen, Susan L.
AU - Steele, Linda
AU - Ashworth, Alan
AU - Garcia Closas, Montserrat
AU - Houlston, Richard
AU - Swerdlow, Anthony
AU - Orr, Nick
AU - KConFab Consortium
N1 - Publisher Copyright:
© The Author(s) 2020. Published by Oxford University Press.
Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine
PY - 2021/4/6
Y1 - 2021/4/6
N2 - BACKGROUND: The etiology of male breast cancer (MBC) is poorly understood. In particular, the extent to which the genetic basis of MBC differs from female breast cancer (FBC) is unknown. A previous genome-wide association study of MBC identified 2 predisposition loci for the disease, both of which were also associated with risk of FBC.METHODS: We performed genome-wide single nucleotide polymorphism genotyping of European ancestry MBC case subjects and controls in 3 stages. Associations between directly genotyped and imputed single nucleotide polymorphisms with MBC were assessed using fixed-effects meta-analysis of 1380 cases and 3620 controls. Replication genotyping of 810 cases and 1026 controls was used to validate variants with P values less than 1 × 10-06. Genetic correlation with FBC was evaluated using linkage disequilibrium score regression, by comprehensively examining the associations of published FBC risk loci with risk of MBC and by assessing associations between a FBC polygenic risk score and MBC. All statistical tests were 2-sided.RESULTS: The genome-wide association study identified 3 novel MBC susceptibility loci that attained genome-wide statistical significance (P < 5 × 10-08). Genetic correlation analysis revealed a strong shared genetic basis with estrogen receptor-positive FBC. Men in the top quintile of genetic risk had a fourfold increased risk of breast cancer relative to those in the bottom quintile (odds ratio = 3.86, 95% confidence interval = 3.07 to 4.87, P = 2.08 × 10-30).CONCLUSIONS: These findings advance our understanding of the genetic basis of MBC, providing support for an overlapping genetic etiology with FBC and identifying a fourfold high-risk group of susceptible men.
AB - BACKGROUND: The etiology of male breast cancer (MBC) is poorly understood. In particular, the extent to which the genetic basis of MBC differs from female breast cancer (FBC) is unknown. A previous genome-wide association study of MBC identified 2 predisposition loci for the disease, both of which were also associated with risk of FBC.METHODS: We performed genome-wide single nucleotide polymorphism genotyping of European ancestry MBC case subjects and controls in 3 stages. Associations between directly genotyped and imputed single nucleotide polymorphisms with MBC were assessed using fixed-effects meta-analysis of 1380 cases and 3620 controls. Replication genotyping of 810 cases and 1026 controls was used to validate variants with P values less than 1 × 10-06. Genetic correlation with FBC was evaluated using linkage disequilibrium score regression, by comprehensively examining the associations of published FBC risk loci with risk of MBC and by assessing associations between a FBC polygenic risk score and MBC. All statistical tests were 2-sided.RESULTS: The genome-wide association study identified 3 novel MBC susceptibility loci that attained genome-wide statistical significance (P < 5 × 10-08). Genetic correlation analysis revealed a strong shared genetic basis with estrogen receptor-positive FBC. Men in the top quintile of genetic risk had a fourfold increased risk of breast cancer relative to those in the bottom quintile (odds ratio = 3.86, 95% confidence interval = 3.07 to 4.87, P = 2.08 × 10-30).CONCLUSIONS: These findings advance our understanding of the genetic basis of MBC, providing support for an overlapping genetic etiology with FBC and identifying a fourfold high-risk group of susceptible men.
KW - Breast Neoplasms, Male/chemistry
KW - Case-Control Studies
KW - Confidence Intervals
KW - Female
KW - Genetic Predisposition to Disease
KW - Genome-Wide Association Study
KW - Humans
KW - Linear Models
KW - Linkage Disequilibrium
KW - Male
KW - Odds Ratio
KW - Polymorphism, Single Nucleotide
KW - Quantitative Trait Loci
KW - Receptors, Estrogen
UR - http://www.scopus.com/inward/record.url?scp=85102459182&partnerID=8YFLogxK
U2 - 10.1093/jnci/djaa101
DO - 10.1093/jnci/djaa101
M3 - Journal article
C2 - 32785646
AN - SCOPUS:85102459182
SN - 1052-6773
VL - 113
SP - 453
EP - 461
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 4
ER -